Positive Results for aTTP Announced by New England Journal of Medicine

Patients with acquired thrombotic thrombocytopenic purpura (aTTP) showed a significantly improved platelet count response after treatment with Cablivi® according to the New England Journal of Medicine's Phase 3 trial results. A…

Continue Reading Positive Results for aTTP Announced by New England Journal of Medicine